SPY366.78+4.72 1.30%
DIA300.58+3.96 1.33%
IXIC12,315.91+117.17 0.96%

Biocept Q3 EPS $(0.43) Beats $(0.47) Estimate, Sales $6.60M Beat $2.51M Estimate

Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.47) by 8.51 percent. This is a 72 percent decrease over losses of $(0.25) per share from the same

· 11/12/2020 16:08
Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.47) by 8.51 percent. This is a 72 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $2.51 million by 162.95 percent. This is a 331.65 percent increase over sales of $1.53 million the same period last year.